Board
AlphaNet, Inc. was founded in 1995 by 3 Alphas and according to our bylaws at least 50% of our board members must be either diagnosed with Alpha-1, known carriers of the gene for Alpha-1, or the spouse, child, or parent of a person diagnosed with Alpha-1. Our Board of Directors is focused on the provision of comprehensive health management services to individuals affected by Alpha-1, which includes contributing toward the advancement of clinical research, public and patient education, and health management.
Board Officers
Robert Greene, Jr.
Chairman
Wyoming, MI
Miekeleen Hart
Vice Chair
Akron, OH
Dell Witcher
Treasurer
Vestavia Hills, AL
Grant Wood
Secretary
Salt Lake City, UT
Board Members
Mark Delvaux
President and Chief Executive Officer
Coral Gables, FL
Charles "Tim" Frost
Member
Vienna, VA
Albert Garcia
Board Member
Miami, FL
Tammy McGuinness
Member
Sammamish, WA
Diana Patterson
Member
Colfax, LA
David Pusey
Member
Fort Collins, CO
Robert Sandhaus, MD, PhD, FCCP
Senior Medical Director and Executive VP
Bow Mar, CO
Staff
Our corporate staff enables us to meet our mission of improving the lives of individuals affected by Alpha-1 Antitrypsin Deficiency.
Corporate Staff
Mark Delvaux
President and Chief Executive Officer
Patrick Lunn
Director of Finance
Christine Lanser Yllanes
Director of Communications
Victoria Vaccaro
Director of Human Resources
Carol Morse
Director of Strategy Implementation
Veronika Dosseva
Accountant
Christen Chacon
Content Manager
Sheri Allison
IT Manager
Curtis Christensen
IT Network Administrator
David Fleitas-Velez
IT Network Administrator
Natalie Gonzalez
Office Assistant
Kelly Reyes
Payroll Administrator
Kathie Sivesind
Logistics Coordinator
Paul Kludt
Special Projects Manager
Coordinators
Each AlphaNet Coordinator has Alpha-1 Antitrypsin Deficiency and, thus, is able to uniquely understand the issues and concerns of other individuals living with Alpha-1. AlphaNet Coordinators are spread across the United States and subscribers to AlphaNet are assigned to a specific AlphaNet Coordinator based on the augmentation therapy prescribed and their geographic location.